Gastroenterology

Interleukin-18 as a drug repositioning opportunity for inflammatory bowel disease: A Mendelian randomization study

Interleukin-18 as a drug repositioning opportunity for inflammatory bowel disease: A Mendelian randomization study

Source link




Related posts

Commensal microbiota induces colonic barrier structure and functions that contribute to homeostasis

Newsemia

In Men, Low BMI Tied to Later Inflammatory Bowel Disease

Newsemia

H. pylori treatment, vitamins, garlic reduce gastric cancer mortality

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy